patient

"Three months after the launch of a new drug, I'd treated about a hundred patients. A colleague said he'd done over a thousand - most using imported jabs bought on the black market."

That means the Essence Phase 3 study, evaluating the treatments in patients ages 6 to 13, failed their primary end points.

Duke-NUS remains a leader in medical research and education, committed to improving patient care through scientific innovation.

This new test, which demonstrates 96 percent accuracy, offers renewed hope to patients who have struggled for recognition and reliable answers.

In later stages, patients often experience "sundowning," a period of increased confusion and agitation that tends to occur later in the day.